Essential Cancer Proteins and Key Pathway Identification of Cancer through Bioinformatic Analysis

Pathway analysis is crucial for deciphering the molecular mechanisms underlying cancer by identifying essential proteins within biological pathways. This study introduces a comprehensive framework for pathway analysis to uncover proteins associated with cancer pathogenesis. A computational approach exploring protein-protein interaction (PPI) networks and cancer gene datasets is applied to identify critical proteins involved in cancer progression. The methodology includes preprocessing gene data, using centrality metrics to detect vital proteins, and conducting pathway enrichment analysis to uncover dysregulated cancer pathways. This study identifies 44 critical proteins in PPI networks linked to breast, lung, colorectal, and ovarian cancers. These proteins span ten key pathways for regulating cell cycles, growth, and differentiation. The research emphasizes the significant roles of proteins like TP53, BRCA1, RPS27A, PCNA, CDK1, and CTNNB1 in cancer development, offering important insights into their functional impact on cancer-related pathways. The pathway analysis approach elucidates the molecular basis of cancer and advances precision oncology research. The study examines major cellular pathways, highlighting potential targets for therapeutic intervention and personalized treatment strategies. Future endeavours aim to translate identified essential cancer proteins into clinical practice through multidisciplinary collaboration and implementation strategies, promising the development of effective cancer treatment strategies.